JENNIFER S. BUELL

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Protagenic Therapeutics, Inc.\new

Filing Date Source Excerpt
2025-03-10 Jennifer S. Buell(1) 76,563(8) 2 %

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-04-25